» Articles » PMID: 10441107

Decreased Sodium and Increased Transient Outward Potassium Currents in Iron-loaded Cardiac Myocytes. Implications for the Arrhythmogenesis of Human Siderotic Heart Disease

Overview
Journal Circulation
Date 1999 Aug 10
PMID 10441107
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients with chronic iron overload may develop a cardiomyopathy manifested by ventricular arrhythmias and heart failure. We hypothesized that iron-loaded cardiomyocytes may have abnormal excitability.

Methods And Results: We examined a new model of human iron overload, the Mongolian gerbil given repeated injections of iron dextran. In ventricular myocytes, we measured iron concentration and distribution, action potential, sodium and potassium currents, and sodium channel protein. We showed for the first time that (1) the iron content of gerbil ventricular cardiomyocytes was increased to amounts similar to those of patients with iron-induced cardiomyopathy; (2) the overshoot and duration of the cardiac action potential decreased; (3) sodium current was reduced, steady-state inactivation was enhanced, and single-channel currents were unchanged; and (4) transient outward potassium current was increased, but inwardly rectifying potassium current was unchanged. Neonatal rat cardiomyocytes incubated with iron for 1 to 3 days showed similar changes, and levels of cardiac sodium channel proteins were unchanged.

Conclusions: Abnormal excitability and heterogeneous cardiac iron deposition may cause the arrhythmogenesis of human siderotic heart disease.

Citing Articles

Heterogeneity of ventricular action potentials in neonatal rat cardiomyocytes and methodological aspects of patch clamp measurements.

Syren P, Zlatopolskaia A, Bruehl C, Schoffel A, Caspari T, Hess C Front Physiol. 2025; 16:1537345.

PMID: 40061457 PMC: 11885515. DOI: 10.3389/fphys.2025.1537345.


The role of iron overload and ferroptosis in arrhythmia pathogenesis.

Shen J, Fu H, Ding Y, Yuan Z, Xiang Z, Ding M Int J Cardiol Heart Vasc. 2024; 52:101414.

PMID: 38694269 PMC: 11060960. DOI: 10.1016/j.ijcha.2024.101414.


Research advances on molecular mechanism and natural product therapy of iron metabolism in heart failure.

Zhang T, Luo L, He Q, Xiao S, Li Y, Chen J Eur J Med Res. 2024; 29(1):253.

PMID: 38659000 PMC: 11044586. DOI: 10.1186/s40001-024-01809-4.


Cardiac complications in thalassemia throughout the lifespan: Victories and challenges.

Wood J Ann N Y Acad Sci. 2023; 1530(1):64-73.

PMID: 37902424 PMC: 10841366. DOI: 10.1111/nyas.15078.


Hereditary hemochromatosis with homozygous C282Y HFE mutation: possible clinical model to assess effects of elevated reactive oxygen species on the development of cardiovascular disease.

Shizukuda Y, Rosing D Mol Cell Biochem. 2023; 479(3):617-627.

PMID: 37133674 DOI: 10.1007/s11010-023-04726-y.